BRIEF-Enigma biomedical announces research collaboration agreement with Biogen Inc and Merck
July 25, 2016 at 17:28 PM EDT
* Collaboration focused on qualification and validation of Tau imaging agent developed by Merck, MK-6240
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.